Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹947 Cr
up ₹76.8 Cr vs Dec 2023
- Stocks held
- 38
- up 2 vs Dec 2023
- Top 10 weight
- 55.8%
- of the portfolio in its ten largest
- Cash & debt
- 0.7%
- cash, money market and debt
- Moves this month
- 4 in · 2 out
- added to 10, trimmed 10
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In March 2024 it disclosed 38 stocks worth ₹947 Cr, up ₹76.8 Cr from Dec 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.6%), Cipla Limited (7.2%), Apollo Hospitals Enterprise Limited (6.9%); the ten largest together made up 55.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 74.3% of its equity. Cash and debt stood at 0.7%. Compared with Dec 2023 the fund entered 4 new stocks and exited 2.
Against 226 other Sectoral / Thematic funds
Concentration
74%
Top-10 weight is higher than 74% of peers
Breadth
38%
Holds more stocks than 38% of peers
Cash
9%
Holds more cash than 9% of peers
Holdings in March 2024
Download CSVEvery line the fund disclosed, with the change against Dec 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.56%
- Δ weight
- up 0.83 pts
- Value
- ₹128 Cr
- Δ value
- up ₹17.7 Cr
- Status
- Added
- Weight
- 7.15%
- Δ weight
- down 0.01 pts
- Value
- ₹67.7 Cr
- Δ value
- up ₹5.4 Cr
- Status
- Added
- Weight
- 6.88%
- Δ weight
- down 0.17 pts
- Value
- ₹65.1 Cr
- Δ value
- up ₹3.8 Cr
- Status
- Added
- Weight
- 5.91%
- Δ weight
- up 0.78 pts
- Value
- ₹56 Cr
- Δ value
- up ₹11.3 Cr
- Status
- Added
- Weight
- 5.49%
- Δ weight
- down 1.08 pts
- Value
- ₹52 Cr
- Δ value
- down ₹5.2 Cr
- Status
- Trimmed
- Weight
- 3.55%
- Δ weight
- down 1.03 pts
- Value
- ₹33.6 Cr
- Δ value
- down ₹6.2 Cr
- Status
- Trimmed
- Weight
- 3.48%
- Δ weight
- down 0.13 pts
- Value
- ₹32.9 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 3.45%
- Δ weight
- down 1.28 pts
- Value
- ₹32.7 Cr
- Δ value
- down ₹8.5 Cr
- Status
- Trimmed
- Weight
- 3.16%
- Δ weight
- down 0.02 pts
- Value
- ₹29.9 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 3.15%
- Δ weight
- down 0.51 pts
- Value
- ₹29.8 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 2.94%
- Δ weight
- up 0.01 pts
- Value
- ₹27.8 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 2.92%
- Δ weight
- up 0.27 pts
- Value
- ₹27.7 Cr
- Δ value
- up ₹4.6 Cr
- Status
- Added
- Weight
- 2.65%
- Δ weight
- up 0.11 pts
- Value
- ₹25.1 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 2.36%
- Δ weight
- up 0.05 pts
- Value
- ₹22.3 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 2.35%
- Δ weight
- down 0.83 pts
- Value
- ₹22.3 Cr
- Δ value
- down ₹5.4 Cr
- Status
- Trimmed
- Weight
- 2.33%
- Δ weight
- up 0.34 pts
- Value
- ₹22.1 Cr
- Δ value
- up ₹4.8 Cr
- Status
- Added
- Weight
- 2.22%
- Δ weight
- down 0.66 pts
- Value
- ₹21 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 2.03%
- Δ weight
- down 0.36 pts
- Value
- ₹19.2 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 1.80%
- Δ weight
- up 1.80 pts
- Value
- ₹17 Cr
- Δ value
- up ₹17 Cr
- Status
- New
- Weight
- 1.70%
- Δ weight
- up 0.41 pts
- Value
- ₹16.1 Cr
- Δ value
- up ₹4.9 Cr
- Status
- Added
- Weight
- 1.68%
- Δ weight
- up 0.11 pts
- Value
- ₹15.9 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 1.61%
- Δ weight
- down 0.32 pts
- Value
- ₹15.2 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 1.58%
- Δ weight
- up 0.40 pts
- Value
- ₹15 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Weight
- 1.39%
- Δ weight
- up 0.76 pts
- Value
- ₹13.2 Cr
- Δ value
- up ₹7.7 Cr
- Status
- Added
- Weight
- 1.34%
- Δ weight
- up 1.34 pts
- Value
- ₹12.7 Cr
- Δ value
- up ₹12.7 Cr
- Status
- New
- Weight
- 1.33%
- Δ weight
- up 0.90 pts
- Value
- ₹12.6 Cr
- Δ value
- up ₹8.9 Cr
- Status
- Added
- Weight
- 1.27%
- Δ weight
- down 0.15 pts
- Value
- ₹12 Cr
- Δ value
- down ₹30 L
- Status
- Trimmed
- Weight
- 1.25%
- Δ weight
- up 0.20 pts
- Value
- ₹11.8 Cr
- Δ value
- up ₹2.7 Cr
- Status
- Added
- Weight
- 1.16%
- Δ weight
- up 0.10 pts
- Value
- ₹11 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Weight
- 1.15%
- Δ weight
- up 0.10 pts
- Value
- ₹10.8 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Weight
- 1.12%
- Δ weight
- up 0.29 pts
- Value
- ₹10.6 Cr
- Δ value
- up ₹3.4 Cr
- Status
- Added
- Weight
- 1.10%
- Δ weight
- down <0.01 pts
- Value
- ₹10.4 Cr
- Δ value
- up ₹84 L
- Status
- Added
- Weight
- 1.05%
- Δ weight
- down 0.02 pts
- Value
- ₹9.9 Cr
- Δ value
- up ₹62 L
- Status
- Added
- Weight
- 0.78%
- Δ weight
- up 0.78 pts
- Value
- ₹7.4 Cr
- Δ value
- up ₹7.4 Cr
- Status
- New
- Weight
- 0.76%
- Δ weight
- down 0.05 pts
- Value
- ₹7.2 Cr
- Δ value
- up ₹11 L
- Status
- Added
- Weight
- 0.59%
- Δ weight
- up 0.59 pts
- Value
- ₹5.6 Cr
- Δ value
- up ₹5.6 Cr
- Status
- New
- Weight
- 0.57%
- Δ weight
- down 0.04 pts
- Value
- ₹5.4 Cr
- Δ value
- up ₹9 L
- Status
- Added
- Weight
- 0.55%
- Δ weight
- down 0.26 pts
- Value
- ₹5.2 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 0.53%
- Δ weight
- down 0.83 pts
- Value
- ₹5 Cr
- Δ value
- down ₹6.8 Cr
- Status
- Trimmed
- 364 DAYS T - BILLDebt
- Weight
- 0.13%
- Δ weight
- up 0.13 pts
- Value
- ₹1.2 Cr
- Δ value
- up ₹1.2 Cr
- Status
- New
What changed, Dec 2023 to Mar 2024
New New positions (4)
- Glenmark Pharmaceuticals Limited1.8% · ₹17 Cr
- Aster DM Healthcare Limited1.3% · ₹12.7 Cr
- Max Healthcare Institute Limited0.8% · ₹7.4 Cr
- Vijaya Diagnostic Centre Limited0.6% · ₹5.6 Cr
Exited Exited (2)
- Mankind Pharma Limitedwas 1.5% · ₹12.6 Cr
- Biocon Limitedwas 0.9% · ₹8.2 Cr
Added Biggest additions
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2023, the weight rose most in Healthcare Services (+2.1 pts), and fell most in Pharmaceuticals & Biotechnology (−1.7 pts) and Pharmaceuticals (−0.3 pts).
- Healthcare Services21.4% → 23.5%+2.1 pts
- Pharmaceuticals & Biotechnology76.0% → 74.3%−1.7 pts
- Pharmaceuticals0.8% → 0.6%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Mar 2021 | Mar 2023 | Sep 2023 | Dec 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 86.4% | 77.2% | 75.7% | 76.0% | 76.0% | 74.3% |
| Healthcare Services | 9.1% | 19.8% | 20.9% | 21.4% | 21.4% | 23.5% |
| Healthcare Equipment & Supplies | 1.4% | 1.9% | 1.5% | 1.1% | 1.1% | 1.1% |
| Insurance | — | — | 0.8% | 0.6% | 0.6% | 0.6% |
| Pharmaceuticals | — | 1.1% | 1.2% | 0.8% | 0.8% | 0.6% |
Allocation in Mar 2024change vs Dec 2023
- Pharmaceuticals & Biotechnology (25)74.3%▼ 1.7 pts
- Healthcare Services (10)23.5%▲ 2.1 pts
- Healthcare Equipment & Supplies (1)1.1%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Mar 2024
0.7%
▼ 0.8 pts vs Dec 2023
- Cash alone
- 0.5%
- cash and net receivables
- A year earlier
- 1.9%
- Mar 2023 · now ▼ 1.3 pts
- Last 12 months
- 0.7% – 2.2%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.